Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1100 µg Brimonidine Tartrate Implant[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
2200 µg Brimonidine Tartrate Implant[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
3400 µg Brimonidine Tartrate Implant[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬
4Brimonidine[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
5Brimonidine tartrate[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[2] 13, 90 💬
6Brimonidine Tartrate Posterior Segment Drug Delivery System (Brimo PS DDS) Applicator System[1] Brimonidine[1] Brimonidine 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬
[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 90 💬